Source: Annual Congress 2001 - News in inhalation therapy and devices in childhood asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. G. M. Arets, A. W. A. Kamps, H. J. L. Brackel, P. G. H. Mulder, N. A. V. Vermue, C. K. van der Ent (Utrecht, Zwolle, Rotterdam, Zeist, The Netherlands). Anti-inflammatory treatment in 5-10-year-old mildly symptomatic children with asthma: can we objectively measure the effect?. Eur Respir J 2001; 16: Suppl. 31, 3303

Member's Comments

No comment yet.

Related content which might interest you: Long-term efficacy of 1 year anti-inflammatory treatment in paediatric patients with mild persistent asthma Source: Eur Respir J 2004; 24: Suppl. 48, 379s Year: 2004 Anti-inflammatory effect of low dose theophylline in school children with bronchial asthma Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013 Treatment of severe childhood asthma: what’s the evidence? Source: Annual Congress 2005 - Difficult asthma in children Year: 2005 Induced sputum in children with intermitent and persistent asthma: the effect to treatment Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007 L-carnitine improves the asthma control in children with moderate persistent asthma Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 The oral corticosteroid sparing effect of omalizumab in patients with severe chronic asthma: Is there a difference when you become 12 years old? Source: Annual Congress 2011 - Treating childhood asthma Year: 2011 Omalizumab in children with severe asthma (SA): Which parameters improve after a 16 week trial? Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 Mepolizumab for severe eosinophilic asthma: a comparison of efficacy in children, adolescents, and adults Source: International Congress 2018 – New developments in paediatric asthma Year: 2018 Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 A new observer independent method to assess therapy response in children with severe asthma based on daily lung function Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 The cost-efficacy of combined anti-inflammatory therapy in the treatment of children in severe persistent asthma Source: Eur Respir J 2003; 22: Suppl. 45, 134s Year: 2003 Knemometry assessment of short-term lower leg growth in children with asthma treated with fluticasone propionate/formoterol combination therapy Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015 Physical activity in daily life: A new outcome to evaluate young adult survivors of bronchopulmonary dysplasia? Source: Annual Congress 2013 –Assessment methods involved in the physiotherapy treatment in different patient populations Year: 2013 The relationship between asthma and obesity in children: is it a case of over diagnosis? Source: Annual Congress 2007 - Risk factors for childhood asthma: cohort studies Year: 2007 Low-level laser therapy as a supplementary treatment in patients with moderate to severe persistent asthma Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 Late Breaking Abstract - Daily physical activity in patients with severe asthma and the effect of anti-IL5 therapy. Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019 One year following a real life experience of omalizumab for moderate to severe persistent allergic asthma in Malta Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Impact of cough on quality of sleep and effect of anti-tussive treatment in children: An observational study Source: Annual Congress 2011 - Paediatric respiratory infection: signs, symptoms and sequelae Year: 2011 Late Breaking Abstract - Daily physical activity in patients with severe eosinophilic asthma and the effect of anti-IL5 therapy. Source: International Congress 2018 – New pharmacological strategies in airway diseases Year: 2018 Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013